PEB directors?
Printable View
PEB heading back to 90 plus .....nice
Just failed last time ...this time will be different methinks
Hope the sermon is a rip roarer this arvo.
Harbour Asset Management first brought in at 19 cents and from memory took up the rights issue last year at 55 cents. Encouraging that they are still buying at current prices.
What a difference a day makes-24 little hours. Apologies for the plagirism.
If you are embarrassed to ask from the floor, one of you Facebook users might like to put it up as a question.
I have never used FB in my life, so it won't be me, but they have a facility for posing curly questions to be answered at the AGM. Please phrase it in a way that won 't get their gander up (so not you New Guy :D)
100K to buy at 70c and 100k to sell at 74c - someone is making a spread?
Either way, one will go by 5 pm
Hopefully some kind soul will be posting updates/interesting questions and answers on here! I am mobile at the moment, on a long train journey, only have 3G! Will break up my boredom at least!
Interesting to note that as of now XRO and PEB over the last 3 months have ended up with the same movements:
XRO $32.50 - $23.70 - 27.08%
PEB $1.00 - $0.73 -27.00%
crashed my pc lol
oh geez - this stream is going to be painful!
W69, it must be quite warm - a lady just removed her puffer jacket :t_up:
wait - he said something about tens of...dammit
This is so frustrating!!!
Think Ill come back after dinner
Wait Ill take the dog for a walk, its bound to start then
Any body bring their sample along
lets just do this ourselves...
Sorry just kidding, the above just released to market :)
The words and pictures up on NZX site\
https://www.nzx.com/companies/PEB/announcements/254217
https://www.nzx.com/files/attachments/198958.pdf
Do find it interesting that none of the NPN sales were made until after 31st March 2014. Quite a time delay there.
Yes, the 'TIMELINE OF ACTIVITY FOR DEVELOPMENT OF US SALES' section is very interesting. May help explain why such low sales numbers were in our last report. All those signups that generated enthusiasm may have barely been 'getting underway' during that reporting period.
There is a network issue on location. We are recording the event and will make it available via delayed recording if we cannot restore the connection.
We are sorry for the inconvenience.
Regards,
David Lutterman | CEO
OneRoom Automated Webcasting
Direct + 09 379 6115 | Mobile + 021 592 800 | Web + www.oneroom.co.nz
There is a network issue on location. We are recording the event and will make it available via delayed recording if we cannot restore the connection.
We are sorry for the inconvenience.
Regards,
David Lutterman | CEO
OneRoom Automated Webcasting
Direct + 09 379 6115 | Mobile + 021 592 800 | Web + www.oneroom.co.nz
Sounds like same old-same old after having a read of the report... not much point in hanging out for the video if that is all they are going to say! Unless some interesting questions are asked and enlightening answers given, nothing has changed and we will probably see the SP drop to where it was before ~60-65c is my guess.
Balance, was that you selling?
I simply don't know why people thought there were going to be thousands of tests done last year. I would still be positive about this product had they reported today that the only tests they had done were out of the Nz laboratory... I have to believe traders on the thread simply wanted the golden goose before the eggs where even laid. wonker, where's wonker? right when I see him boy, I'll give him a roasting...
I think a bit will depend on what the lady heading the US team has to say.
There will be nothing new or special said in the presentations. Hancocks and MAC will get some juicy bits over the sausage rolls and gumboot tea, afterwards
was Jackie even introduced?
I hear from the floor that Oneroom have stuck a camera up the pipe to check for faults in the network
What glimpses we did get indicated Cellmid may do well in the future.:)
DD, "they're turning hostile, how long until the sausage rolls come out?!"
In there powerpoint they write "Target gross revenues of over NZ$100 million after five full years of trading with very attractive margins".
Was it really necessary to write "with very attractive margins". It kind of more than affirms the 5 years goal, but a promise of spectacular profits, when they could have just stuck to target of 100 million after fives years.
How many presentations have I been to that were turned into embarrassing disasters by tech failures.
Anybody at the presentation who can give us an update, eg are they having question time and is it any good?
Thanks to the person who typed up so much! Two out-takes for me so far
1. They've re-confirmed the goal as readily attainable, in fact now they're saying 'more' than $100m
2. They intend to roll out the e-commerce functionality beyond nz market
If Oneroom ever IPO, someone remind me not to bother....
SP down to 71c
Maybe the internet is full up.
Seems to be "room" for improvement.:)
CS: nah, he was shot earlier, and is the sausage in the rolls.......
Likely to end down for the day now I suppose... <70c?
The whole thing is an antler climax
DD: That would explain why they taste so (insert any plethora of offensive words to Moosie here). Dammit Swanny we're running out of ideas here, I don't want you having to make any outrageous claims about tens of thousands of sales! What about that reporter, let's point him out!
Well, I would love to hear if anything special was asked during question time, but I am feeling positive.
We basically have a solid reason now for the low number of tests last report. We all thought 'they signed up these providers, and we are seeing no corresponding revenue, therefore signing up providers means very little and the sales plan is failing'. In reality, we really don't know how much of a sales boost those networks have given as it clearly takes a long time before things start rolling. I am hoping for a much bigger spike in revenue in the next report to correlate with this information. CMS coverage may not be as required as people are thinking based on this info, but that is just pure speculation. We have to wait and see.
They have once again confirmed their 5 year plan is on track. At least they are sticking to their guns here. Presumably they can see the slow but steady increases in sales and are happy with what is going on. They have reaffirmed they are investing in themselves to bring about this goal. Sales team increases, new products, etc.
Good to hear triage is apparently out this year (will be interesting to see that it is) but also interesting that no mention was made of CxColorectal. They are clearing focusing in one area and have decided this is the best path to getting the cashflow positive.
Its all 'more of the same', which is not exciting, but ultimately should mean good things long term. I think they are missing their chances to keep their shareholders up to date and happy regarding sales traction but ah well.
Last year at the university they couldn't get the power point presentation to work. I remember hoping it was not a reflection of how they made their sales pitches. This year it seems its the webcast that lets them down - it doesn't build confidence when they can't apparently even make a presentation without looking like amateurs
Guess we will have to wait for the troops on the front line to get back to us.:)
Blis really do not come across as tech-savvy or even business-savvy for that matter. Their web site is very poorly designed, with multiple product options most of which really don't look much different, and when one sends an email to info@pacificedge.co.nz (as posted on their Home page) one gets the following reply:
Thank you for your email,
I no longer work at Pacific Edge Limited. Please email brent.pownall@pacificedgedx.com or contact Pacific Edge's main reception at +64 3 479 5800 to address your query.
Kind Regards.
Caroline Cross
Sloppy.
There were 114 users viewing this thread .After all this lack of progress and technical stuff up .tomorrow there will probably be only one viewer.That will be yourself just wondering if the things still alive.
After a quick gloss over todays release, it appears to be all the same old info, same graphs etc. This stuff all has a tone to it as if it was a prospectus to sign up new shareholders only, a very basic 'salesy' feel with little substance. It's like it's all they know.. they're stuck in this same phase of trying to raise capital. We're past that, or at least we should be. Maybe they are struggling to adjust to where the company is now as some have previously suggested - almost as if they're lost with what to do next. Just my opinion...
Being wary of being shot diwn by snaipi and team. One positive I took from Jacquis brief talk in question time was this is really the I only new test offered in 20 years to urologists in US and while prostrate cancer innovations are a dime a dozen for doctors to evaluate. Cx bladder is the only one in the bladder cancer fiekd.
From this :
2013 - "Dunedin-based bladder cancer detection test inventor Pacific Edge believes it could be turning over $100 million a year in the United States within five years, following the registration of its own diagnostic laboratory in Pennsylvania".
To:
"After 5 full years of trading"
Not impressed.
Hard to please some folks, huh? I understand that oneroom.co.nz was the provider for the webcast, not PEB. So why put the boot into PEB for the webcast failure? Oh, I know, it’s about investor psychology. Makes ya feel good to keep on kicking, just like a bully does.
My room mate had a few emails with PEB to a general address a few days ago, all of which were answered within 20 minutes. He didn't call that sloppy, just efficient.
Cant wait to see what the ODT has to say about this.:)
I sent the ODT a newstip about lots of angry shareholders round the country, impressed by PEB's webinar initiative but angry as hell about OneRoom's failure to deliver.
A pretty much as expected AGM and review of the last year, with an onward and forward message I thought.
Good to see a firm reinforcement of both the financial target and cash position, and it was good to hear a little from Jackie at the end too, she did well as it was all impromptu.
“Target gross revenues of over NZ$100 million after five full years of trading with very attractive margins”
“Sufficient funds in place for planned development and growth strategy in existing markets”
Like any AGM one gets more out of attending, once all the usual routine presentations are done, there’s the opportunity to ask a little more over a nice glass of wine and compare notes with others.
Also good to see some maturity at question time unlike a lot of the childish rubbish on this forum.
My understanding is that PEB sold the exclusive rights to market Cxbladder in Spain (only?) to Oryzon, some years ago now. I recall some talk on ST of it waiting on CE approval - but it has that, and as far as I can see is all good to go as far as the red tape is concerned.
But now we are told:
In Spain, we have an agreement with Oryzon. They have chosen to launch Cxbladder in Spain to support secondary detection of bladder cancer and we are working with them to build this specific dataset and are hoping to see Oryzon underway within the next 12 months.
Is "secondary detection" a point of difference?
Why would the business model in Europe be different to the ROW?
Snooze another 12 months away?
There is no slippage Balance, only a clarification of something that could have been interpreted several ways. Was probably clarified in response to exactly such a request to do so.
Nobody asked how many tests they expected to perform this year at question time, afterwards though perhaps.
So what's the drill now with One Room? Shouldn't they be making the replay available by now? Do they do this by hand?
Seriously - anyone got a GoPro? Lets do an IPO.
PEB can learn a lot from the way DIL managed its interaction with the market in terms of tracking sales and goals - quarterly updates on sales numbers, locations and customer types.
Why PEB will not do it unfortunately tells me volume now about how credible and really confident they are about achieving their $100m target - especially after Swann's 'tens of thousands of tests in 2014'.
I wouldn't actually compare the IT sector with the biotech(molecular diagnostic) sector, they both have squiggly lines and the syllable 'tech' though.
CS explained that they see their customers as the insurers rather than the patients or urologists, so the key reporting metrics may be any of those, but he did also though in response to a question raised obligate to consider more frequent updates.
I wouldn't object to quarterly reports also actually, but at the end of the day I'm ok with companies with good fundamental propositions that just get on with business too. Quarterly reports may just attract more short term speculators, we've seen enough of them come and go this year already.
I would say they really quite confident in their NZ$100M target, in fact they just told their target was over that.
Thanks for reporting back MAC. Swans comment about the Insurer's being their Customer reinforces my take of things. If it is covered , it will sell.
CMS will likely influence this. When they announce coverage, this thing will rock. Be in or be left behind...
No no . come back!
Seriously, how do you see sales progressing without Insurance coverage?
Just take time to look back on recent posts and no one has the foggiest clue where the Company is going,when it's going to get there and if it does,how long it's going to take.There is a chance it's going to succeed but it's about as certain as Argentina beating someone in rugby...IMHO..
Absolutely,
They have set a modest numerical financial target, have already built a lab to match that capacity, they have raised all the capital they need to fund that growth, they have completed clinical trials and regulatory approvals, they have a first mover advantage, a disruptive technology, several clinical value propositions over the incumbent technology, they offer a one third reduction in costs to their customers (insurers), the market (respectful cancer patients) is growing each year, they have a time saving product in a market with an ever increasing shortage of urologists, and they have a marketing strategy that appears well considered.
Yes, I'm a content shareholder of Pacific Edge, whilst I recognise we are in the early days of the launch and the trajectory is a difficult estimation, I have some confidence in their position and greater business plan and in a lot more research in the background.
And, we have a positive a set of affirmations from the company today;
“Sufficient funds in place for planned development and growth strategy in existing markets”
“As at 31 March 2014, cash and equivalents of $20.4 million and no debt”
“Expect revenue to grow as we expand our footprint in the US”
“Expand our sales presence in the United States and drive ambitious revenue target”
“Target gross revenues of over NZ$100 million after five full years of trading with very attractive margins”
Chairmans address at ASM in 2009
We have a very clear strategy for significant growth over the next 5 years
in two very broad directions. In both those wide marketplaces significant growth and change is beginning........
We will see the beginnings of this trend in this financial year; but the lead-times from testing, approving and specifying our products hit the market, can take up to 3 years. Consequently we will only see the beginnings of the revenue growth in this fiscal year and much more in the next fiscal year.
Whoops, wrong thread. Sorry there is no similarity between chips for GPS and test tubes. My apologies